Login / Signup

Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs.

Jodi L LaytonBrian LewisCharles RyanTomasz M BeerOliver Sartor
Published in: The oncologist (2018)
It is common for patients to have limited access to oral antineoplastics or to discontinue treatment because of cost. Such oral treatments are also discontinued because of toxicity, disease progression, or death, resulting in unused portions of these medications. Policies for the subsequent use or destruction of unused drugs exist, but none completely address the need for methods of recycling back to the patients in need. This article addresses this wastefulness and ways to minimize it so that more patients benefit.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • peritoneal dialysis
  • prognostic factors
  • public health
  • patient reported outcomes
  • oxidative stress
  • drug induced